CANDEL THERAPEUTICS I
5.0900
07-十一月-24 15:59:58
15 分钟延时
股票
-0.2400
-4.50%
今日范围
5.0700 - 5.3600
ISIN
N/A
来源
NASDAQ
-
CAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Glioma
13 2月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
05 2月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Candel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Pancreatic Cancer
12 12月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
Candel Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
09 11月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
Candel Therapeutics Presents Preclinical Data from its enLIGHTEN™ Discovery Platform at SITC
04 11月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
03 11月 2023 12:00:00 条件 Nasdaq GlobeNewswire
-
18 10月 2023 11:00:00 条件 Nasdaq GlobeNewswire
-
27 9月 2023 09:40:53 条件 Nasdaq GlobeNewswire
-
26 9月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
Candel Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
06 9月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Candel Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
10 8月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
Candel Therapeutics to Participate in the Canaccord Genuity 43rd Annual Growth Conference
02 8月 2023 08:00:29 条件 Nasdaq GlobeNewswire
-
13 6月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
08 6月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Candel Therapeutics to Participate in the 2023 Jefferies Healthcare Conference
05 6月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
Candel Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
11 5月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
Candel Therapeutics Announces Upcoming Presentations at ASGCT and ASCO
02 5月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
Candel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Non-Small Cell Lung Cancer
17 4月 2023 08:00:00 条件 Nasdaq GlobeNewswire